For instance, blockade of IL-17 signaling may be useful for the prevention of CRC in genetically susceptible populations, such as FAP (familial adenomatous polyposis) patients that harbor germline mutations in the Apc tumor suppressor gene. Here, IL17A is linked to colorectal carcinoma.